Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

1,095 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,095 results

Not applicableLooking for participantsNCT07720414
What this trial is testing

Effects of GLP-1 RAs on Human Lactation Outcomes

Who this might be right for
LactationWeight Loss
University of Colorado, Denver 18
Not applicableStudy completedNCT00497133
What this trial is testing

Alpha-Cell Sensitivity to GLP-1 in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
University of Copenhagen 20
Not applicableUnknownNCT05196958
What this trial is testing

Interest of GLP1 Analogues in Overweight Type 2 Diabetic Patients With Chronic Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel DiseasesDiabetes Mellitus, Type 2
Fondation Hôpital Saint-Joseph 20
Not applicableStudy completedNCT04151849
What this trial is testing

Effects of Diabetes Medications on Adrenal Function and Intestinal Microbiota

Who this might be right for
Type 2 Diabetes
University of Tartu 23
Early research (Phase 1)Study completedNCT01501084
What this trial is testing

Effects of the GLP-1 Exenatide on Satiety in Lean and Obese Women

Who this might be right for
Obesity
University of California, Los Angeles 34
Testing effectiveness (Phase 2)Study completedNCT01832532
What this trial is testing

A Pilot Study of the Effects on Sleep Disordered Breathing (SDB) When Using the Drug Liraglutide for 4 Weeks

Who this might be right for
Sleep ApneaSleep Disordered Breathing
Children's Hospital Medical Center, Cincinnati 34
Not applicableWithdrawnNCT01930448
What this trial is testing

Mechanisms of Diabetes Control After Weight Loss Surgery, Sub-study #1

Who this might be right for
Gastric Bypass SurgeryGastric BandingType 2 Diabetes
St. Luke's-Roosevelt Hospital Center
Large-scale testing (Phase 3)WithdrawnNCT02229240
What this trial is testing

Albiglutide Versus Placebo Added-on to Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline
Not applicableLooking for participantsNCT05663515
What this trial is testing

A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs

Who this might be right for
Pancreatic Cancer
AstraZeneca 24,000
Early research (Phase 1)Study completedNCT01967589
What this trial is testing

Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long Acting GLP-1 Analogue (NNC0113-0987) in Healthy Male Subjects

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 82
Post-approval studies (Phase 4)Not Yet RecruitingNCT07100691
What this trial is testing

Gastric Emptying With Metoclopramide in GLP-1 Agonist Patients Undergoing Elective Surgery

Who this might be right for
Pulmonary Aspiration During Anaesthetic InductionGastric Emptying TimePreoperative Risk Assessment+1 more
Mater Misericordiae University Hospital 80
Post-approval studies (Phase 4)Study completedNCT03893526
What this trial is testing

Effect of Neprilysin on Glucagon-Like Peptide-1 in Patients With Type 2 Diabetes

Who this might be right for
Type2 Diabetes
University of Copenhagen 12
Post-approval studies (Phase 4)Active Not RecruitingNCT07325435
What this trial is testing

Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists

Who this might be right for
Type 2 Diabetes (T2DM)
MaryAnn Banerji 60
Post-approval studies (Phase 4)Study completedNCT03361098
What this trial is testing

DECREASE: Dapagliflozin Plus Exenatide on Central REgulation of Appetite in diabeteS typE 2

Who this might be right for
Type 2 Diabetes MellitusObesity
Amsterdam UMC, location VUmc 65
Not applicableEnded earlyNCT06273163
What this trial is testing

Identifying Strategies to Curtail Weight Regain After GLP-1 Receptor Agonist Treatment Cessation

Who this might be right for
Obesity
University of Texas Southwestern Medical Center 39
Testing effectiveness (Phase 2)Study completedNCT00571324
What this trial is testing

Effect of Exendin-(9-39) on Glycemic Control in Subjects With Congenital Hyperinsulinism

Who this might be right for
Congenital Hyperinsulinism
Diva De Leon 9
Not applicableNot Yet RecruitingNCT07783113
What this trial is testing

Dietary Supplement for Telogen Effluvium Associated With GLP-1 Receptor Agonist Use

Who this might be right for
Alopecia
Farmoquimica S.A. 48
Not applicableUnknownNCT02076880
What this trial is testing

SLEEVEDIAB To Explore the Early and Late Metabolic Effects of Sleeve Gastrectomy in Obese Patients

Who this might be right for
Severe ObesityType 2 Diabetes
University Hospital, Montpellier 14
Large-scale testing (Phase 3)WithdrawnNCT04287179
What this trial is testing

SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S
Testing effectiveness (Phase 2)Study completedNCT02541734
What this trial is testing

Effect of Gelofusine on GLP1-receptor Imaging

Who this might be right for
Diabetes Mellitus, Non-Insulin-DependentDiabetes Mellitus
Radboud University Medical Center 12
Next Page